All News

“These observations strongly suggest an underdiagnosis of COVID-19 in this population of cancer patients and a major underestimation of SARS-CoV-2 contribution as a cause of death in cancer patients,” the authors wrote. “The management of cancer patients with febrile respiratory symptoms in this period of the epidemic should, therefore, be particularly careful even in the absence of SARS-CoV-2 detection.”

A laryngectomy choir offers rehabilitation and inspiration to patients after throat cancer.

It's important to celebrate the mini-victories along the cancer journey, whether it's with your favorite food or a small parade.

Cancer changes everything about one’s self-image, but that doesn’t mean it is a negative outcome.

Ethan Zohn, "Survivor: Africa" winner, discusses how his winner’s mentality helped him through treatment and how leaning on others has been key in survivorship.

We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.

U.S. Supreme Court Justice Ruth Bader Ginsburg, 87, has announced that she is currently undergoing chemotherapy for a cancer recurrence.

According to the lead study investigator, work needs to be done to ensure financial toxicity is not a deterrent to clinical trial enrollment and that trial sponsors and payers should consider trial expense reimbursement.

It's easy to accept certain challenging side effects from the cancer journey as a "new normal", something you can't shake no matter what. But even with cancer fatigue feeling insurmountable, there are ways to handle it.

From U.S. Supreme Court Justice Ruth Bader Ginsburg being released from the hospital after an infection related to treatment for pancreatic tumor to Alex Trebek giving an update on the treatment of his stage 4 pancreatic cancer just days ahead of his 80th birthday, here’s what’s making the headlines in the cancer space this week.

In both diagnosis and treatment of cancer, there is a growing role for radiation drugs that are injected, ingested or inserted.

When it comes to hepatocellular carcinoma (HCC), doctors have a handful of treatment options at their disposal. But how do they decide what’s best?

A survivor of male breast cancer goes through what he wishes he knew before a breast cancer diagnosis.

CURE®’s summer recipe series continues with a simple three bean vegetable chili recipe that's loaded with protein and fiber.

The manufacturer is working with the Food and Drug Administration to address any requests including changes to the protocol of the MELANI-01 trial to enhance patient safety.

Channeling the fear of unwanted change into the hard-fought promise of a transformed life.

The Food and Drug Administration’s Oncologic Drugs Advisory Committee voted in favor of the agency approving belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma who have previously received at least four therapies.

The Food and Drug Administration in May approved 7 therapies to treat patients with non-small cell lung cancer. And although one expert notes that few are considered “practice changing”, patients should not be disheartened considering there have been so many advancements in the treatment of the disease.

The Multiple Myeloma Research Foundation’s newly launched CureCloud is a registry designed to collect clinical and genomic information about patients. Its goals are to help researchers discover treatments for various subtypes of the disease and let patients know whether they have any of 70 genetic aberrations associated with myeloma.

Dr. Pat Basu, president and CEO of Cancer Treatment Centers of America discusses the fear surrounding cancer screenings during the COVID-19 pandemic and finding the right balance between what is an essential visit and what can be done using telemedicine.

Plucking a fat and juicy blueberry from a new mastectomy bra reminded this breast cancer survivor that life can still be sweet.

Although the study failed to meet its goal of progression-free survival, overall survival data are currently not yet available, and follow-up will continue until the next planned analysis.

Most of the data from the recent approvals of several non-small cell lung cancer drugs don’t distinguish themselves regarding efficacy or safety to what was already available before the flurry of approvals in May, according to Dr. Timothy Burns.

Ten percent of women who received a hysterectomy and salpingectomy, or removal of the fallopian tubes, during the study period had a family history of breast or ovarian cancer.

A recent data analysis found that most women diagnosed with ovarian cancer (92%) experienced abdominal and pelvic-related symptoms and visited a physician with this complaint anywhere from six to 70 months prior to diagnosis.

“Having new options is important, particularly when patients have already been through chemotherapy and some of the other therapies that are available,” said Dr. John P. Leonard.

“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.

From cancer to COVID-19, our patient stories can help others take sickness and disease seriously.

From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.